NeoImmuneTech, Inc. (KOSDAQ: 950220)
South Korea
· Delayed Price · Currency is KRW
1,624.00
-121.00 (-6.93%)
Sep 10, 2024, 9:00 AM KST
NeoImmuneTech Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Sep '24 Sep 9, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 31,361 | 40,041 | 78,963 | 203,671 | - | - | |
| Market Cap Growth | -31.30% | -49.29% | -61.23% | - | - | - | |
| Enterprise Value | -20,690 | -37,279 | -56,272 | 42,088 | - | - | |
| Last Close Price | 1586.00 | 2025.00 | 3995.00 | 10350.00 | - | - | |
| PE Ratio | - | -3.75 | -6.53 | -18.79 | - | - | |
| PB Ratio | 2.70 | 0.53 | 0.66 | 1.26 | - | - | |
| P/FCF Ratio | -0.76 | -0.79 | -1.76 | -5.57 | - | - | |
| P/OCF Ratio | -0.76 | -0.80 | -1.86 | -6.01 | - | - | |
| EV/EBITDA Ratio | 0.57 | 0.71 | 1.02 | -0.84 | - | - | |
| EV/EBIT Ratio | 0.53 | 0.67 | 0.97 | -0.81 | - | - | |
| EV/FCF Ratio | 0.50 | 0.74 | 1.25 | -1.15 | - | - | |
| Debt / Equity Ratio | 0.04 | 0.05 | 0.04 | 0.04 | 0.03 | 0.02 | |
| Debt / FCF Ratio | -0.06 | -0.08 | -0.11 | -0.16 | -0.10 | -0.19 | |
| Quick Ratio | 4.45 | 5.36 | 7.14 | 7.57 | 7.91 | 35.93 | |
| Current Ratio | 4.87 | 5.61 | 7.19 | 8.17 | 8.96 | 36.48 | |
| Return on Equity (ROE) | -59.09% | -54.90% | -42.88% | -42.62% | -30.44% | -16.71% | |
| Return on Assets (ROA) | -31.83% | -30.30% | -22.25% | -22.95% | -18.02% | -11.52% | |
| Return on Capital (ROIC) | -36.17% | -34.34% | -24.87% | -25.45% | -18.99% | -11.74% | |
| Earnings Yield | -29.72% | -133.37% | -76.50% | -25.77% | - | - | |
| FCF Yield | -132.78% | -126.25% | -56.84% | -17.97% | - | - | |
| Buyback Yield / Dilution | 0.14% | -0.08% | -3.68% | -15.26% | -1.50% | -39.27% | |
| Total Shareholder Return | 0.14% | -0.08% | -3.68% | -15.26% | -1.50% | -39.27% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.